- Acumen Powered by Robins Kaplan LLP®
- Affirmative Recovery
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Commercial/Project Finance and Real Estate
- Corporate Governance and Special Situations
- Corporate Restructuring and Bankruptcy
- Domestic and International Arbitration
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Telecommunications Litigation and Arbitration
- Wealth Planning, Administration, and Fiduciary Disputes
Acumen Powered by Robins Kaplan LLP®
Ediscovery, Applied Science and Economics, and Litigation Support Solutions
March 30, 2023Minnesota Attorney General Keith Ellison and Robins Kaplan Partner Tara Sutton Give Opening Statements in Minnesota’s Lawsuit Against JUUL
March 28, 2023Robins Kaplan LLP Announces 2023 Leadership Council on Legal Diversity (LCLD) Fellow and Pathfinder
March 22, 2023Benchmark Litigation Names Robins Kaplan 2023 Minnesota Law Firm of the Year
April 3, 2023Conference of Tribal Lending Commissioners
April 11-13, 2023Mass Torts Made Perfect Seminar
April 19, 2023FBA Women in MDL, Mass and Class Leadership
March 2023Unintended Consequences of Banning Noncompete Agreements
March 26, 2023What I’ll Be Watching for in the Amgen Oral Arguments
March 2023How an Investor Can Lose More Than Just Their Investment
September 16, 2022Uber Company Systems Compromised by Widespread Cyber Hack
September 15, 2022US Averts Rail Workers Strike With Last-Minute Tentative Deal
September 14, 2022Hotter-Than-Expected August Inflation Prompts Massive Wall Street Selloff
Find additional firm contact information for press inquiries.
Find resources to help navigate legal and business complexities.
Rayna Kessler Appointed Liaison Counsel in Exactech Multi-District Litigation
December 20, 2022
Robins Kaplan LLP is pleased to announce that on December 12, 2022, New York partner Rayna Kessler was appointed liaison counsel in the multi-district litigation In re: Exactech Polyethylene Orthopedic Products Liability Litigation, MDL No. 3044, 1:22-md-03044-MMH. The MDL was recently formed by the Judicial Panel on Multidistrict Litigation and involves hip, knee, and ankle replacement devices manufactured by Exactech, and was assigned to Judge Nicholas G. Garaufis, U.S.D.J., of the Eastern District of New York.
In her leadership position, Rayna is responsible for working closely with the Plaintiff Executive Committee, communicating with the Court and other counsel to ensure local and MDL procedures are followed, advise parties of important developments in the MDL, and serve as a resource to other plaintiff attorneys who may file claims within the MDL.
To date, Exactech has recalled approximately 150,000 hip, knee, and ankle replacement devices. The recall first became public in February 2022 when Exactech issued an Urgent Medical Device Correction Notice informing surgeons that most knee inserts manufactured from 2004 to 2022, as well as total ankle replacement devices manufactured from 2017 to 2022, were packaged in non-conforming bags. The defective bags did not contain a secondary barrier layer of ethylene vinyl alcohol to reinforce the device’s resistance to oxygen, which can cause inserts to wear out prematurely or become damaged after implantation. On August 11, 2022, Exactech expanded its recall to include total hip replacement devices manufactured from 2004 to 2021.
Because of these defects, some patients have experienced tissue damage, bone loss/osteolysis, instability, painful inflammation, and other injuries, leading to complex revision surgeries and extensive recovery time. Robins Kaplan is advocating for patients who have received Exactech hip, knee, and ankle devices to be made aware of how the recall may affect them, and represent a number of plaintiffs who are injured by these products in the MDL.
“I look forward to working with the Court and the parties to progress our MDL forward as efficiently as possible,” Kessler said. “We have a wonderful group of attorneys appointed to leadership positions with a vast amount of experience with medical device litigation. It is an honor to serve as a resource for this team, including to assist with New York local rules and procedure.”
Rayna Kessler is a partner in the firm’s New York office. Her practice focuses on complex civil and multivenue litigation in a range of matters that span products liability, medical malpractice, pharmaceuticals, and medical devices, as well as child sex abuse involving large institutions.
“Rayna is a skilled attorney who is dedicated to helping our clients and ensuring that the MDL progresses effectively,” said Tara Sutton, Chair of the National Mass Tort Group of Robins Kaplan. “I’m confident that she will be a great asset for the management of the MDL and assisting counsel with their Exactech claims.”
An experienced complex civil litigator, Rayna has served in court-appointed lead liaison counsel roles in several New Jersey Multicounty State Court Litigations, including In re: Benicar (Olmesartan Medoxomil) New Jersey Multicounty Litigation, MCL Case No. 299; In re: Abilify, MCL Case No. 626; and In re: Taxotere Litigation, MCL Case No. 628.
Robins Kaplan continues to evaluate and accept claims related to Exactech hip, knee, and ankle products. Our case evaluation is free and confidential. To find out if we can help you with a potential claim, please call 1.800.811.9972 or complete our online contact form.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.